Navigation Links
Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial

re permitted to roll over to pegylated interferon plus ribavirin for up to 48 weeks of total treatment; all eligible patients elected to do so.

"These results support our hypothesis that valopicitabine can be administered in combination with pegylated interferon and ribavirin," said Douglas Mayers, M.D., executive vice president and chief medical officer of Idenix Pharmaceuticals. "We are very pleased with the viral kinetics and HCV RNA clearance rates observed in patients treated with triple combination therapy in this study and look forward to further development of this combination."

About Valopicitabine

Valopicitabine is an investigational nucleoside polymerase inhibitor being evaluated in ongoing clinical trials for the treatment of hepatitis C. The most common adverse events reported in valopicitabine clinical trials to date include nausea, vomiting, fatigue, diarrhea, headache, flu-like symptoms and depression. Idenix is developing valopicitabine in collaboration with Novartis Pharma AG.

About Hepatitis C

HCV infection is the most common chronic blood-borne infection in the United States.(1) The Centers for Disease Control and Prevention estimates that 4 million Americans have been infected with HCV, and 2.7 million of these carry chronic HCV infections.(2) Hepatitis C-related liver failure is the most common indication for liver transplantation in the United States.(2) As the prevalence of severe liver disease attributable to hepatitis C rises, deaths due to complications from hepatitis C infection, currently 8,000 to 10,000 per year in the United States, are increasing and are expected to triple by 2010.(3)

Conference Call Information

Idenix will hold a conference call today at 8:30 a.m. EDT. To access the call please dial (800) 774-5358 U.S./Canada or (706) 758-9475 International and enter passcode 3143678 or to listen to a live webcast of the call, go to "Calendar of Events" in the Idenix Investor Center at
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Idenix Reports Results from Two Phase IIb Studies of the Combination of Valopicitabine and Pegylated Interferon in Hepatitis C Genotype-1 Patients at the 42nd Annual Meeting of the European Association for the Study of the Liver
2. New Data Show Pfizers Axitinib Prolonged Overall Survival in Advanced Pancreatic Cancer When Combined with Standard of Care Chemotherapy
3. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
4. Low-Dose Steroid Combined With Lenalidomide Prolongs Survival Compared With High-Dose Steroid for Multiple Myeloma Treatment
5. RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments
6. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
7. Repros Reports That Proellex Has Demonstrated Superior Efficacy and Safety in Endometriosis When Compared to Standard of Drug Care
8. Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
9. Clinical Trial Results Change Standard of Care for Pancreatic Cancer Patients, Future Therapies Discussed
10. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
11. Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO

Post Your Comments:
(Date:11/25/2009)... , , COLLEGE PARK, Md., Nov. 25 /PRNews...company developing a shaving cream-like foam that ... in the Most Promising Security Idea category of t...ls announce today. ,, Selected from more than 1...pitched their invention at the GSC Security Summit...
(Date:11/25/2009)... , , NEW YORK, Nov. 25 /PRNewswire/...esearch report is available in its catalogue: ,...d Forecasts to 2015 ,, http://www.reportlinke...-Analysis-and-Forecasts-to-2015.html ,, United...ts to 2015 ,, Summary ,, This report is an...
(Date:11/25/2009)... , , WALTHAM, Mass., Nov. 25 /PRNew...MRG), the global authority on medical technology m...t for trauma fixation devices will continue to see... recent economic slowdown. MRG,s US Markets for T...t will remain highly dynamic over the next five ye...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 13US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3U of A honored for research that could help 30 million Brazilians 9238 1CareGuide Adds New Management Team Members 51470 1CareGuide Adds New Management Team Members 51470 2Golds Gym Debunks Americas Most Common Fitness Myths 51465 1Golds Gym Debunks Americas Most Common Fitness Myths 51465 2Golds Gym Debunks Americas Most Common Fitness Myths 51465 3
(Date:11/27/2009)..., Nov. 27 Preventing di...d fortunately every year, new vaccines are being a...accines boost immunity for the same period of time... needed to keep immunity strong? ,, In this m...rican Academy of Pediatrics, Michael Pichichero MD...
(Date:11/27/2009)...enaCare Holdings has announced that it has become ...e of the largest nonprofit organizations dedicated.... , Delray Beach, FL (Voc...OTCBB: XCHO), a company specializing in the market... products, has announced today that is has become ...
(Date:11/27/2009)... SEATTLE, Nov. 27 Allrecipes.com ... Thanksgiving traffic numbers, with more than 2.8 ...iding a clear picture of what was served on the bi...giving meal in 2009 weighed in at 2,225 calories p...feast. According to the Allrecipes site, Sweet Po...
(Date:11/27/2009)...pecialist manufacturers who use medical load cells...s of dollars by bringing in technology partner Fli...rs of pro-active medical manufacturers are calling... of their projects, ensuring that progress will no...otentially outdated technology. , ...
(Date:11/26/2009)...J., Nov. 27 The diabetes populatio... next 25 years and annual medical spending on the ...$113 billion today, according to a study published...tional Changing Diabetes ® Program (NCDP), a...s by a team from the University of Chicago. ,, ...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4
...art Inc. announced,that the first DuraHeart(TM) Le...in October at the University of Tokyo Hospital in ...ward an early application for approval,for manufac...etically levitated,impeller. The product received ...
...evenue Guidance, HOUSTON, Oct. 31 Cyberonics, In... for Medicare and Medicaid Services,(CMS) has publ...System,(OPPS) Final Rule and Ambulatory Payment Cl...erapy generators and $7,234,for insertion of assoc...
... and Asia-Pacific trials to be, presented at 59th ... Study of Liver Diseases ...ayer HealthCare Pharmaceuticals, Inc. and Onyx Pha...ation for the Study,of Live Diseases (AASLD) demon...
... nurtures creative,thinking. In this time of econo...mers, and employees, innovations in marketing, sal...market share., Network with and learn from leadin...Enable Companies to Survive and Thrive,During the ...
...ing nerves, waking people from a coma, 6 year chro...tigue/fibromyalgia, whiplash, carpel tunnel, and r...using advanced magnetic therapy techniques develop... year chronic sciatica back pain, 15- and 25-year ...
...shed finds that, while about 40 percent of women s...cent indicate that those issues are a source of si...Massachusetts General Hospital (MGH) physician app...se which are truly bothersome and affect a woman,s...
Other Medicine News:Health News:Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS 2Health News:Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS 3Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 2Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 3Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 4Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 5Health News:New Analyses Confirm Nexavar's Efficacy and Safety in Multiple Patient Subsets With Liver Cancer 6Health News:Survive the Economic Downturn Through Innovations in Integrated Customer Strategies 2Health News:BiomagScience Introduces Breakthrough Health Therapy Kits 2Health News:BiomagScience Introduces Breakthrough Health Therapy Kits 3Health News:BiomagScience Introduces Breakthrough Health Therapy Kits 4Health News:BiomagScience Introduces Breakthrough Health Therapy Kits 5Health News:While prevalent, sexual problems in women not always associated with distress 2
... and ESU devices. Suitable for use in Dr.'s Office...he FreshAire filter technology is the next generat...ng the clinician unparalleled plume capture and od...t, economical. The VersaVac2® is the premier c...
...ation System provides a more intelligent solution ...ume. This next generation smoke evacuator combine...er requested features and benefits into a unique, ...ted to ten different air flow settings. From low ...
The VitalVac® Surgical Smoke Evacuator
Fixation Straps
Medicine Products: